IVIg for Treatment of Severe Refractory Heparin-Induced Thrombocytopenia

BACKGROUND: Heparin-induced thrombocytopenia (HIT) complicated by severe thrombocytopenia and thrombosis can pose significant treatment challenges. Use of alternative anticoagulants in this setting may increase bleeding risks, especially in patients who have a protracted disease course. Additional t...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Chest
Hlavní autoři: Padmanabhan, Anand, Jones, Curtis G., Pechauer, Shannon M., Curtis, Brian R., Bougie, Daniel W., Irani, Mehraboon S., Bryant, Barbara J., Alperin, Jack B., Deloughery, Thomas G., Mulvey, Kevin P., Dhakal, Binod, Wen, Renren, Wang, Demin, Aster, Richard H.
Médium: Artigo
Jazyk:Inglês
Vydáno: American College of Chest Physicians 2017
Témata:
Antithrombotic Therapy
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5812774/
https://ncbi.nlm.nih.gov/pubmed/28427966
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.chest.2017.03.050
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky